{
  "schema_version": 1,
  "updated": "2026-01-12",
  "categories": ["syndrome", "formula", "herb", "compound", "therapy"],
  "refs_library": [
    {
      "id": "ref_wu2024_molcancer_hbp",
      "title_en": "Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery",
      "title_zh": "中医药治疗肝胆胰系统肿瘤：从临床证据到药物发现（综述）",
      "journal": "Molecular Cancer",
      "year": 2024,
      "doi": "10.1186/s12943-024-02136-2",
      "url": "https://doi.org/10.1186/s12943-024-02136-2"
    },
    {
      "id": "ref_vella2025_cancers_sr",
      "title_en": "Unconventional Treatments for Pancreatic Cancer: A Systematic Review",
      "title_zh": "胰腺癌的非常规/补充疗法：系统综述",
      "journal": "Cancers (MDPI)",
      "year": 2025,
      "doi": "10.3390/cancers17091437",
      "url": "https://www.mdpi.com/2072-6694/17/9/1437",
      "doi_url": "https://doi.org/10.3390/cancers17091437"
    },
    {
      "id": "ref_frontiers2023_phagepeptide_pc",
      "title_en": "Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach",
      "title_zh": "噬菌体展示肽用于胰腺癌诊断与治疗：一种替代性思路",
      "journal": "Frontiers in Microbiology",
      "year": 2023,
      "doi": "10.3389/fmicb.2023.1231503",
      "url": "https://www.frontiersin.org/articles/10.3389/fmicb.2023.1231503/full",
      "doi_url": "https://doi.org/10.3389/fmicb.2023.1231503"
    },
    {
      "id": "ref_shi32_adv_pc_tcm",
      "title_en": "Clinical Study of 32 Patients with Advanced Pancreatic Cancer Treated with TCM",
      "title_zh": "晚期胰腺癌32例中医药治疗临床观察（上传PDF）",
      "journal": "(uploaded PDF)",
      "year": null,
      "doi": null,
      "url": null,
      "file": "Clinical_Study_of_32_Patients_.pdf"
    }
  ],
  "items": [
    {
      "id": "tcm_syndrome_4types",
      "type": "syndrome",
      "evidence_level": "textbook/clinical experience",
      "name_zh": "中医辨证分型（示例：四型）",
      "name_en": "TCM pattern differentiation (example: 4 types)",
      "summary_zh": "部分资料将胰腺癌相关证候分为多种类型，用于指导治法与方药选择。",
      "summary_en": "Some sources describe multiple TCM patterns to guide treatment principles and formulas.",
      "key_points": [
        {
          "pattern": { "zh": "痰浊瘀结", "en": "Phlegm-turbidity with blood stasis" },
          "principle": { "zh": "和解少阳，内泻热结", "en": "Harmonize Shaoyang; purge internal heat-congestion" },
          "formula": { "zh": "大柴胡汤合血府逐瘀汤加减", "en": "Da Chai Hu Tang + Xue Fu Zhu Yu Tang (modified)" },
          "notes": { "zh": "症状描述见来源；需注册中医师辨证。", "en": "Symptoms are source-described; requires qualified TCM clinician." }
        }
      ],
      "use_cases": [],
      "stage": [],
      "components": {},
      "risks": [
        { "zh": "仅用于健康教育；不替代个体化诊疗。", "en": "Educational only; not a substitute for individualized care." }
      ],
      "interactions": [],
      "refs": [
        { "label": "TCM article (html)", "citation": "turn9file2:L1-L1" }
      ]
    },
    {
      "id": "tcm_patterns_jaundice",
      "type": "syndrome",
      "evidence_level": "clinical guidance (experience-based)",
      "name_zh": "肝胆湿热证（胰头癌伴黄疸）",
      "name_en": "Liver–gallbladder damp-heat pattern (jaundice)",
      "summary_zh": "资料提到胰头癌伴黄疸、舌红苔黄腻等，可辨为肝胆湿热证，治以清肝利胆、祛湿降浊，方药茵陈蒿汤加减。",
      "summary_en": "Source describes jaundice presentation mapped to damp-heat; Yin Chen Hao Tang modifications suggested.",
      "key_points": [
        {
          "zh": "方药：茵陈蒿汤加减；药物包括茵陈、大黄、栀子等。",
          "en": "Formula: Yin Chen Hao Tang modified; herbs include Yin Chen, Da Huang, Zhi Zi."
        }
      ],
      "use_cases": [],
      "stage": [],
      "components": {},
      "risks": [
        {
          "zh": "含大黄等泻下药，腹泻/肠梗阻风险者需谨慎并遵医嘱。",
          "en": "Contains purgative herbs (e.g., Da Huang); caution with diarrhea/obstruction risks; clinician supervision needed."
        }
      ],
      "interactions": [],
      "refs": []
    },
    {
      "id": "tcm_patterns_midlate",
      "type": "syndrome",
      "evidence_level": "clinical guidance (experience-based)",
      "name_zh": "中晚期常见：脾虚湿阻 / 肝阴亏虚",
      "name_en": "Common mid–late patterns: spleen deficiency with dampness / liver yin deficiency",
      "summary_zh": "资料提到中晚期可见脾虚湿阻及肝阴亏虚证，分别可用陈夏六君汤加减与一贯煎合二至丸加减，并列出常用药材。",
      "summary_en": "Source notes these patterns and suggests Chenxia Liu Jun Tang or Yiguan Jian + Erzhi Wan modifications with example herbs.",
      "key_points": [
        {
          "zh": "脾虚湿阻：党参、白术、茯苓、法半夏等组成陈夏六君汤加减。",
          "en": "Spleen deficiency dampness: Chenxia Liu Jun Tang (e.g., Dang Shen, Bai Zhu, Fu Ling, Fa Ban Xia)."
        },
        {
          "zh": "肝阴亏虚：一贯煎合二至丸加减；如沙参、麦冬、地黄、枸杞子、女贞子等。",
          "en": "Liver yin deficiency: Yiguan Jian + Erzhi Wan (e.g., Sha Shen, Mai Dong, Di Huang, Gou Qi Zi, Nv Zhen Zi)."
        },
        {
          "zh": "常加用：半枝莲、蛇六谷、山慈菇、莪术等以清热解毒、活血消癥。",
          "en": "Often mentioned additions: Ban Zhi Lian, She Liu Gu, Shan Ci Gu, E Zhu, etc."
        }
      ],
      "use_cases": [],
      "stage": [],
      "components": {},
      "risks": [
        {
          "zh": "化疗期间如需中药，应关注相互作用；可考虑以针灸等方式减轻不适，避免中药与化疗冲突。",
          "en": "During chemotherapy, consider interaction risk; source suggests acupuncture for symptom relief to avoid herb–chemo conflict."
        }
      ],
      "interactions": [],
      "refs": []
    },

    {
      "id": "integrative_rct_observational",
      "type": "therapy",
      "evidence_level": "secondary summary; heterogeneous studies",
      "name_zh": "中药联合化疗/放疗：部分研究观察结果",
      "name_en": "Herbal medicine combined with chemo/radiotherapy: selected observational findings",
      "summary_zh": "一篇综述/文献汇总提到，部分研究报道中药方联合化疗或放疗在疾病控制率/有效率、KPS等方面优于单纯治疗（具体方药与研究设计需逐条核对原文）。",
      "summary_en": "A review-style source reports some studies where herbal formulas plus chemo/radiotherapy showed higher response/control rates and better KPS; details require checking each original study.",
      "key_points": [
        {
          "zh": "示例：茵陈蒿汤联合替吉奥等；具体以原研究为准。",
          "en": "Example mentions Yin Chen Hao Tang with S-1; verify each original study."
        }
      ],
      "use_cases": ["化疗期支持治疗", "KPS/QoL结局（研究报道）"],
      "stage": ["chemo"],
      "components": {},
      "risks": [
        {
          "zh": "证据质量可能不一；需强调与主治团队沟通、避免延误标准治疗。",
          "en": "Evidence quality varies; coordinate with oncology team and do not delay standard care."
        }
      ],
      "interactions": [],
      "refs": []
    },
    {
      "id": "integrative_workflow",
      "type": "therapy",
      "evidence_level": "expert opinion / clinical experience",
      "name_zh": "中西医协作与风险管理（实践建议）",
      "name_en": "Integrative workflow & risk management (practical guidance)",
      "summary_zh": "来源提到在患者担忧化疗副作用时，可在化疗前以中药增体质，化疗期间优先用针灸等减少不适以避免“中药与化疗冲突”，化疗后再中药调理。",
      "summary_en": "Source suggests: use herbs pre-chemo for conditioning; prefer acupuncture during chemo to reduce side effects and avoid herb–chemo conflicts; resume herbs post-chemo.",
      "key_points": [
        "化疗前：条件允许可做支持性调理",
        "化疗中：优先针灸/非药物支持，减少潜在相互作用",
        "化疗后：再讨论中药调理"
      ],
      "use_cases": ["门诊沟通", "整合流程建议"],
      "stage": ["general", "chemo", "recovery"],
      "components": {},
      "risks": [
        {
          "zh": "任何中药/补充剂应记录并与肿瘤科/药师核对潜在相互作用。",
          "en": "Record all herbs/supplements; cross-check interactions with oncology/pharmacy."
        }
      ],
      "interactions": [],
      "refs": []
    },
    {
      "id": "integrative_principles",
      "type": "therapy",
      "evidence_level": "consensus/clinical safety",
      "name_zh": "如何安全使用中医/整合医学信息",
      "name_en": "How to use integrative/TCM info safely",
      "summary_zh": "中医/整合医学建议仅作为支持治疗信息，不可替代标准肿瘤治疗。",
      "summary_en": "Use TCM/integrative approaches as supportive care, not a replacement for standard oncology treatment.",
      "key_points": [
        { "zh": "任何中药/补充剂务必告知肿瘤团队。", "en": "Tell your oncology team about any herb/supplement you plan to use." },
        { "zh": "重点评估出血风险（抗凝、血小板低、手术前后）。", "en": "Check bleeding risk (anticoagulants, low platelets, surgery)." },
        { "zh": "关注肝肾功能与药物代谢相互作用（如 CYP）。", "en": "Check liver/kidney function and potential CYP interactions." },
        { "zh": "优先选择合规执业者与质量可追溯产品。", "en": "Prefer licensed practitioners and products with quality control." }
      ],
      "use_cases": ["风险沟通", "健康教育"],
      "stage": ["general"],
      "components": {},
      "risks": [
        { "zh": "仅供健康教育，不构成医疗建议。", "en": "Educational only; not medical advice." }
      ],
      "interactions": [],
      "refs": []
    },

    {
      "id": "support_nausea",
      "type": "therapy",
      "evidence_level": "mixed (varies by method)",
      "name_zh": "支持治疗：恶心呕吐",
      "name_en": "Supportive care: Nausea / vomiting",
      "summary_zh": "支持治疗中部分非药物方法（如姜、针灸）有一定证据。",
      "summary_en": "Moderate evidence exists for some non-drug options (e.g., ginger, acupuncture) in supportive care.",
      "key_points": [
        { "zh": "记录诱因（高脂、辛辣、进食量）。", "en": "Track triggers (fat, spice, portion size)." },
        { "zh": "若持续/严重或出现警讯需就医。", "en": "Escalate to clinician if persistent, severe, or with red flags." }
      ],
      "use_cases": ["恶心呕吐管理"],
      "stage": ["chemo", "general"],
      "components": {},
      "risks": [
        { "zh": "出现脱水、发热、便血或黄疸加重等需及时就医。", "en": "Seek urgent care for dehydration, fever, blood in stool, or worsening jaundice." }
      ],
      "interactions": [],
      "refs": []
    },
    {
      "id": "support_diarrhea",
      "type": "therapy",
      "evidence_level": "mixed (varies by method)",
      "name_zh": "支持治疗：腹泻/脂肪泻",
      "name_en": "Supportive care: Diarrhea / steatorrhea",
      "summary_zh": "优先补液、低脂饮食；与医生讨论胰酶与感染等原因。",
      "summary_en": "Prioritize hydration, low-fat meals; discuss pancreatic enzymes and infections with clinician.",
      "key_points": [
        { "zh": "记录诱因（高脂、辛辣、进食量）。", "en": "Track triggers (fat, spice, portion size)." },
        { "zh": "若持续/严重或出现警讯需就医。", "en": "Escalate to clinician if persistent, severe, or with red flags." }
      ],
      "use_cases": ["腹泻/脂肪泻管理"],
      "stage": ["chemo", "general"],
      "components": {},
      "risks": [
        { "zh": "出现脱水、发热、便血或黄疸加重等需及时就医。", "en": "Seek urgent care for dehydration, fever, blood in stool, or worsening jaundice." }
      ],
      "interactions": [],
      "refs": []
    },
    {
      "id": "support_appetite",
      "type": "therapy",
      "evidence_level": "mixed (varies by method)",
      "name_zh": "支持治疗：食欲差/体重下降",
      "name_en": "Supportive care: Poor appetite / weight loss",
      "summary_zh": "营养支持（少量多餐+高蛋白）是核心；草药仅在医生知情下讨论。",
      "summary_en": "Nutrition support (high-protein, small frequent meals) is first-line; herbs may be discussed only with clinicians.",
      "key_points": [
        { "zh": "记录诱因（高脂、辛辣、进食量）。", "en": "Track triggers (fat, spice, portion size)." },
        { "zh": "若持续/严重或出现警讯需就医。", "en": "Escalate to clinician if persistent, severe, or with red flags." }
      ],
      "use_cases": ["营养/体重管理"],
      "stage": ["chemo", "recovery", "general"],
      "components": {},
      "risks": [
        { "zh": "出现脱水、发热、便血或黄疸加重等需及时就医。", "en": "Seek urgent care for dehydration, fever, blood in stool, or worsening jaundice." }
      ],
      "interactions": [],
      "refs": []
    },
    {
      "id": "support_pain",
      "type": "therapy",
      "evidence_level": "mixed (varies by method)",
      "name_zh": "支持治疗：疼痛管理",
      "name_en": "Supportive care: Pain management",
      "summary_zh": "镇痛以医学方案为主；可在适当时用身心疗法/针灸辅助舒缓。",
      "summary_en": "Medical pain control is primary; integrative options may support comfort (mind-body, acupuncture) where appropriate.",
      "key_points": [
        { "zh": "若疼痛升级或出现红旗症状（发热、黄疸加重等）需就医。", "en": "Seek medical review for escalation or red flags." }
      ],
      "use_cases": ["疼痛支持"],
      "stage": ["general", "chemo", "recovery"],
      "components": {},
      "risks": [
        { "zh": "出现脱水、发热、便血或黄疸加重等需及时就医。", "en": "Seek urgent care for dehydration, fever, blood in stool, or worsening jaundice." }
      ],
      "interactions": [],
      "refs": []
    },

    {
      "id": "herb_astragalus",
      "type": "herb",
      "evidence_level": "low",
      "name_zh": "黄芪（Astragalus / Huangqi）",
      "name_en": "Astragalus (Huangqi)",
      "summary_zh": "常用于支持调理；证据质量不一。",
      "summary_en": "Commonly used in supportive care; evidence quality varies.",
      "key_points": [],
      "use_cases": ["支持治疗讨论"],
      "stage": ["general", "chemo", "recovery"],
      "components": {},
      "risks": [
        { "zh": "免疫治疗期间需谨慎；关注肝功能。", "en": "May interact with immune therapies; monitor liver enzymes." },
        { "zh": "务必在医生知情下使用。", "en": "Use only with clinician oversight." }
      ],
      "interactions": [],
      "refs": []
    },

    {
      "id": "herb_ginger",
      "type": "herb",
      "evidence_level": "moderate",
      "name_zh": "生姜（Ginger）",
      "name_en": "Ginger",
      "summary_zh": "部分证据支持缓解恶心；耐受因人而异。",
      "summary_en": "Some evidence for nausea relief; individual tolerance varies.",
      "key_points": [],
      "use_cases": ["恶心支持"],
      "stage": ["chemo", "general"],
      "components": {},
      "risks": [
        { "zh": "反酸/溃疡者可能刺激。", "en": "Can irritate reflux/ulcer in sensitive people." },
        { "zh": "大剂量补充剂与抗凝合用需谨慎。", "en": "Be cautious with anticoagulants at high supplemental doses." }
      ],
      "interactions": [],
      "refs": []
    },

    {
      "id": "herb_licorice",
      "type": "herb",
      "evidence_level": "low",
      "name_zh": "甘草（Licorice / Gancao）",
      "name_en": "Licorice (Gancao)",
      "summary_zh": "方剂常见；高剂量可能有副作用。",
      "summary_en": "Often used in formulas; watch side effects with high intake.",
      "key_points": [],
      "use_cases": ["方剂配伍常见药"],
      "stage": ["general"],
      "components": {},
      "risks": [
        { "zh": "过量可能升血压/低钾。", "en": "May raise blood pressure / lower potassium with excessive use." },
        { "zh": "利尿剂/心血管用药者先咨询。", "en": "Discuss if on diuretics or heart meds." }
      ],
      "interactions": [
        { "zh": "可能影响电解质，合并心律相关药物需谨慎。", "en": "Electrolyte effects; caution with rhythm-related drugs." }
      ],
      "refs": []
    },

    {
      "id": "therapy_acupuncture",
      "type": "therapy",
      "evidence_level": "moderate",
      "name_zh": "针灸（Acupuncture）",
      "name_en": "Acupuncture",
      "summary_zh": "部分场景对恶心/疼痛/焦虑有支持性证据。",
      "summary_en": "Supportive evidence exists for nausea/pain/anxiety in some settings.",
      "key_points": [],
      "use_cases": ["恶心", "疼痛", "焦虑支持"],
      "stage": ["chemo", "general", "recovery"],
      "components": {},
      "risks": [
        { "zh": "血小板低/抗凝者评估出血风险。", "en": "Assess bleeding risk (low platelets/anticoagulants)." },
        { "zh": "选择正规机构与无菌操作。", "en": "Use licensed practitioners & sterile technique." }
      ],
      "interactions": [],
      "refs": []
    },
    {
      "id": "therapy_mindfulness",
      "type": "therapy",
      "evidence_level": "moderate",
      "name_zh": "身心疗法（放松/正念）",
      "name_en": "Mind-body (relaxation, mindfulness)",
      "summary_zh": "有助减压/睡眠/应对；相对安全。",
      "summary_en": "May help stress, sleep and coping; safe adjunct.",
      "key_points": [],
      "use_cases": ["睡眠", "压力", "应对支持"],
      "stage": ["general", "chemo", "recovery"],
      "components": {},
      "risks": [
        { "zh": "不可替代医疗。", "en": "Does not replace medical care." },
        { "zh": "若加重焦虑不适则停止。", "en": "Stop if it increases distress." }
      ],
      "interactions": [],
      "refs": []
    },

    {
      "id": "formula_liujunzi",
      "type": "formula",
      "evidence_level": "clinical experience",
      "name_zh": "香砂六君子汤（加减）",
      "name_en": "Xiangsha Liujunzi Tang (modified)",
      "summary_zh": "常用于食欲差、腹胀、便溏等的讨论；需辨证个体化。",
      "summary_en": "Often discussed for appetite/bloating/loose stool patterns; must be individualized.",
      "key_points": [],
      "use_cases": ["食欲差", "腹胀", "便溏（辨证）"],
      "stage": ["general", "recovery"],
      "components": {},
      "risks": [
        { "zh": "可能存在药物相互作用（抗凝、化疗、免疫治疗）。", "en": "Herb–drug interactions are possible (anticoagulants, chemo, immunotherapy)." }
      ],
      "interactions": [],
      "refs": []
    },
    {
      "id": "formula_shenling",
      "type": "formula",
      "evidence_level": "clinical experience",
      "name_zh": "参苓白术散（加减）",
      "name_en": "Shenling Baizhu San (modified)",
      "summary_zh": "用于久泻乏力等讨论；需排除感染/梗阻。",
      "summary_en": "Discussed for chronic loose stools and fatigue patterns; rule out infection/obstruction.",
      "key_points": [],
      "use_cases": ["久泻", "乏力（辨证）"],
      "stage": ["general", "recovery"],
      "components": {},
      "risks": [
        { "zh": "可能存在药物相互作用（抗凝、化疗、免疫治疗）。", "en": "Herb–drug interactions are possible (anticoagulants, chemo, immunotherapy)." }
      ],
      "interactions": [],
      "refs": []
    },
    {
      "id": "formula_xuefu",
      "type": "formula",
      "evidence_level": "clinical experience",
      "name_zh": "血府逐瘀汤（加减）",
      "name_en": "Xue Fu Zhu Yu Tang (modified)",
      "summary_zh": "涉及活血化瘀思路时需重点评估出血风险。",
      "summary_en": "When 'blood stasis' approach is considered, bleeding risk must be reviewed carefully.",
      "key_points": [],
      "use_cases": ["活血化瘀思路（辨证）"],
      "stage": ["general"],
      "components": {},
      "risks": [
        { "zh": "可能存在药物相互作用（抗凝、化疗、免疫治疗）。", "en": "Herb–drug interactions are possible (anticoagulants, chemo, immunotherapy)." }
      ],
      "interactions": [
        { "zh": "与抗凝/抗血小板合用需谨慎并监测。", "en": "Caution with anticoagulants/antiplatelets; monitor." }
      ],
      "refs": []
    },
    {
      "id": "formula_yinchen",
      "type": "formula",
      "evidence_level": "clinical experience",
      "name_zh": "茵陈蒿汤（加减）",
      "name_en": "Yinchenhao Tang (modified)",
      "summary_zh": "黄疸/湿热讨论较多；胆道梗阻需优先医学评估。",
      "summary_en": "Discussed in jaundice/damp-heat contexts; medical evaluation for biliary obstruction is critical.",
      "key_points": [],
      "use_cases": ["黄疸/湿热（辨证）"],
      "stage": ["general"],
      "components": {},
      "risks": [
        { "zh": "可能存在药物相互作用（抗凝、化疗、免疫治疗）。", "en": "Herb–drug interactions are possible (anticoagulants, chemo, immunotherapy)." }
      ],
      "interactions": [],
      "refs": []
    },

    {
      "id": "check_bleeding",
      "type": "therapy",
      "evidence_level": "clinical safety",
      "name_zh": "出血风险清单",
      "name_en": "Bleeding risk checklist",
      "summary_zh": "若使用抗凝/血小板低/手术前后，涉及“活血化瘀”药材需医生评估后再考虑。",
      "summary_en": "If on anticoagulants, have low platelets, or around surgery, avoid 'blood-invigorating' herbs unless clinician approves.",
      "key_points": [],
      "use_cases": ["风险核对"],
      "stage": ["general", "chemo"],
      "components": {},
      "risks": [
        { "zh": "出现皮疹、肿胀、呼吸困难等需紧急就医。", "en": "If you develop rash, swelling, breathing issues—seek emergency care." }
      ],
      "interactions": [],
      "refs": []
    },
    {
      "id": "check_liverkidney",
      "type": "therapy",
      "evidence_level": "clinical safety",
      "name_zh": "肝肾监测清单",
      "name_en": "Liver/kidney monitoring",
      "summary_zh": "不少补充剂经肝肾代谢；建议监测化验，异常需停用并就医。",
      "summary_en": "Many supplements are metabolized by liver/kidney. Monitor labs and stop if abnormalities occur.",
      "key_points": [],
      "use_cases": ["监测核对"],
      "stage": ["general", "chemo"],
      "components": {},
      "risks": [
        { "zh": "出现皮疹、肿胀、呼吸困难等需紧急就医。", "en": "If you develop rash, swelling, breathing issues—seek emergency care." }
      ],
      "interactions": [],
      "refs": []
    },
    {
      "id": "check_quality",
      "type": "therapy",
      "evidence_level": "clinical safety",
      "name_zh": "产品质量与污染",
      "name_en": "Product quality & contamination",
      "summary_zh": "优先第三方检测产品；警惕重金属/掺假。",
      "summary_en": "Prefer products with third-party testing; beware heavy metals and adulteration.",
      "key_points": [],
      "use_cases": ["产品选择核对"],
      "stage": ["general"],
      "components": {},
      "risks": [
        { "zh": "出现皮疹、肿胀、呼吸困难等需紧急就医。", "en": "If you develop rash, swelling, breathing issues—seek emergency care." }
      ],
      "interactions": [],
      "refs": []
    },
    {
      "id": "check_sugar",
      "type": "therapy",
      "evidence_level": "clinical safety",
      "name_zh": "糖醇与胃肠反应",
      "name_en": "Sugar alcohols and GI symptoms",
      "summary_zh": "一些“健康产品”含糖醇，可能加重腹泻/胀气。",
      "summary_en": "Some 'health' products contain sugar alcohols that worsen diarrhea/bloating.",
      "key_points": [],
      "use_cases": ["腹泻/胀气核对"],
      "stage": ["general"],
      "components": {},
      "risks": [
        { "zh": "出现皮疹、肿胀、呼吸困难等需紧急就医。", "en": "If you develop rash, swelling, breathing issues—seek emergency care." }
      ],
      "interactions": [],
      "refs": []
    },

    {
      "id": "faq_31",
      "type": "therapy",
      "evidence_level": "clinical safety",
      "name_zh": "关于补充剂/中药，应该问医生什么？",
      "name_en": "Questions to ask your clinician about supplements",
      "summary_zh": "用这些问题降低使用补充剂/中药的风险。",
      "summary_en": "Use these questions to reduce risk when considering supplements/herbs.",
      "key_points": [
        { "zh": "与我目前化疗/免疫治疗方案是否安全？", "en": "Is it safe with my chemo/immunotherapy regimen?" },
        { "zh": "与我的用药/化验是否有出血风险？", "en": "Any bleeding risk with my meds or labs?" },
        { "zh": "如何监测肝肾功能？", "en": "How to monitor liver/kidney function?" },
        { "zh": "哪些产品/品牌有质量检测？", "en": "Which products/brands have quality testing?" }
      ],
      "use_cases": ["门诊沟通"],
      "stage": ["general", "chemo"],
      "components": {},
      "risks": [
        { "zh": "不要一次同时新增多个产品。", "en": "Do not start multiple new products at once." }
      ],
      "interactions": [],
      "refs": []
    },

    {
      "id": "formula_huachansu",
      "type": "formula",
      "evidence_level": "low",
      "name_zh": "华蟾素（Huachansu）",
      "name_en": "Huachansu",
      "summary_zh": "综述中作为临床研究中出现的中医药制剂之一。临床证据与适应证需以具体试验为准；潜在心律/电解质相关风险需评估，建议仅在医疗监管下使用。",
      "summary_en": "Listed among TCM therapeutics appearing in clinical trials. Indications and benefit/risk should follow specific trials; potential cardiac/electrolyte risks warrant medical supervision.",
      "use_cases": ["辅助治疗研究", "症状支持"],
      "stage": ["chemo"],
      "components": {},
      "risks": [
        { "zh": "潜在心脏相关不良反应风险；禁用于来源不明制剂", "en": "Potential cardiac adverse-event risk; avoid unknown products." }
      ],
      "interactions": [
        { "zh": "与影响心律或电解质的药物合用需谨慎", "en": "Use caution with drugs affecting rhythm or electrolytes." }
      ],
      "refs": [
        { "ref_id": "ref_wu2024_molcancer_hbp", "source_file": "s12943-024-02136-2.pdf" }
      ]
    },
    {
      "id": "compound_icaritin",
      "type": "compound",
      "evidence_level": "low",
      "name_zh": "依卡替尼（Icaritin，天然产物衍生物）",
      "name_en": "Icaritin (natural product-derived compound)",
      "summary_zh": "综述提及其在肝胆胰系统肿瘤的临床研究与药物发现价值。对胰腺癌的临床证据需以具体试验为准；作为药物/成分应关注药代与肝功能监测。",
      "summary_en": "Review highlights clinical evidence and drug-discovery potential in hepatobiliary system cancers. Pancreatic-cancer-specific clinical evidence depends on individual trials; monitor pharmacokinetics and liver function.",
      "use_cases": ["药物发现/临床研究条目"],
      "stage": ["chemo", "general"],
      "components": {},
      "risks": [
        { "zh": "作为药物级干预需遵循试验/处方规范", "en": "Drug-level intervention should follow trial/prescription protocol." }
      ],
      "interactions": [
        { "zh": "可能与肝酶代谢相关药物相互作用，需监测", "en": "Potential CYP-related interactions; monitoring recommended." }
      ],
      "refs": [
        { "ref_id": "ref_wu2024_molcancer_hbp", "source_file": "s12943-024-02136-2.pdf" }
      ]
    },
    {
      "id": "herb_ginseng",
      "type": "herb",
      "evidence_level": "low",
      "name_zh": "人参（Panax ginseng）",
      "name_en": "Ginseng (Panax ginseng)",
      "summary_zh": "作为补充/草本使用较常见，研究多聚焦疲劳、食欲与生活质量等支持性结局；证据质量不一。化疗/免疫治疗期间使用需评估相互作用与血糖、血压影响。",
      "summary_en": "Commonly used supplement; studies focus on supportive outcomes (fatigue, appetite, QoL) with variable quality. During chemo/immunotherapy, assess interactions and effects on glucose/blood pressure.",
      "use_cases": ["乏力", "食欲", "支持治疗"],
      "stage": ["chemo", "recovery"],
      "components": {},
      "risks": [
        { "zh": "可能影响血糖/血压；来源与剂量不确定风险", "en": "May affect glucose/blood pressure; risk from uncertain source/dosing." }
      ],
      "interactions": [
        { "zh": "可能影响免疫调节或CYP代谢通路；用药清单需共享", "en": "Possible immune/CYP pathway effects; share full supplement list with oncology team." }
      ],
      "refs": [
        { "ref_id": "ref_vella2025_cancers_sr", "source_file": "cancers-17-01437.pdf" }
      ]
    },
    {
      "id": "compound_curcumin",
      "type": "compound",
      "evidence_level": "very_low",
      "name_zh": "姜黄素（Curcumin）",
      "name_en": "Curcumin",
      "summary_zh": "多为机制与前临床研究；胰腺癌临床证据有限。作为补充剂高剂量可能增加出血风险或加重胃肠道不适；化疗期不建议自行大剂量使用。",
      "summary_en": "Mostly mechanistic and preclinical evidence; limited clinical data in pancreatic cancer. High-dose supplementation may increase bleeding risk or GI upset; avoid self-prescribed high doses during chemo.",
      "use_cases": ["补充剂讨论", "机制研究"],
      "stage": ["chemo", "general"],
      "components": {},
      "risks": [
        { "zh": "出血风险、胃刺激", "en": "Bleeding risk; GI irritation." }
      ],
      "interactions": [
        { "zh": "与抗凝/抗血小板药物合用需谨慎", "en": "Caution with anticoagulants/antiplatelets." }
      ],
      "refs": [
        { "ref_id": "ref_vella2025_cancers_sr", "source_file": "cancers-17-01437.pdf" }
      ]
    },
    {
      "id": "therapy_phage_peptide_targeting",
      "type": "therapy",
      "evidence_level": "low",
      "name_zh": "噬菌体展示肽靶向策略（研究进展，非TCM）",
      "name_en": "Phage-display peptide targeting (research, non-TCM)",
      "summary_zh": "综述介绍噬菌体展示技术筛选高亲和力肽用于胰腺癌早期检测、靶向递送与治疗的研究进展。属于实验与转化研究方向，不属于中医药治疗；可作为“替代/创新策略”证据条目补充展示。",
      "summary_en": "Review describes phage display to identify high-affinity peptides for early detection, targeted delivery and treatment in pancreatic cancer. This is translational research (non-TCM) and included here as an innovation/alternative strategy reference.",
      "use_cases": ["研究进展", "早筛/靶向递送"],
      "stage": ["general"],
      "components": {},
      "risks": [
        { "zh": "目前主要为研究阶段，临床可及性有限", "en": "Primarily research-stage; limited clinical availability." }
      ],
      "interactions": [
        { "zh": "与临床治疗方案需由肿瘤团队评估", "en": "Integration with care should be assessed by oncology team." }
      ],
      "refs": [
        { "ref_id": "ref_frontiers2023_phagepeptide_pc", "source_file": "fmicb-14-1231503.pdf" }
      ]
    },

    {
      "id": "therapy_integrative_chemo_tcm_overview",
      "type": "therapy",
      "evidence_level": "moderate",
      "name_zh": "中医药联合化疗（整合肿瘤支持治疗）",
      "name_en": "TCM as an adjunct to chemotherapy (integrative oncology supportive care)",
      "summary_zh": "系统综述与部分临床研究提示：在规范化肿瘤治疗基础上，部分中医药干预作为辅助治疗可能改善生活质量（QoL/KPS）并减轻化疗相关不良反应；证据质量与干预类型差异较大，需在肿瘤团队知情与监测下使用。",
      "summary_en": "Reviews and some clinical studies suggest certain TCM interventions, when used alongside standard oncology care, may improve QoL/KPS and reduce chemotherapy-related adverse effects; evidence quality varies by intervention and requires oncology-team oversight.",
      "key_points": [
        "以“支持治疗/整合医学”定位：不替代标准治疗",
        "优先选择有质量控制与临床证据的制剂/干预（并记录具体成分与剂量）",
        "目标更偏向：QoL、食欲、疲劳、化疗相关毒副反应管理"
      ],
      "use_cases": ["化疗期支持治疗", "QoL/KPS改善", "化疗毒性管理（在监测下）"],
      "stage": ["chemo"],
      "components": {},
      "risks": [
        "不可替代标准治疗；避免自行停用/延迟化疗",
        "制剂来源与质量控制差异大（尤其注射剂/复方）",
        "肝肾功能异常、黄疸、感染或血小板低下时需谨慎/暂停并先就医"
      ],
      "interactions": [
        "可能影响肝药酶/凝血（与抗凝/抗血小板药并用需监测）",
        "免疫治疗期间需谨慎（潜在免疫调节作用）"
      ],
      "refs": [
        { "ref_id": "ref_wu2024_molcancer_hbp" },
        { "ref_id": "ref_vella2025_cancers_sr" },
        { "ref_id": "ref_shi32_adv_pc_tcm" }
      ]
    },
    {
      "id": "therapy_tcm_chemo_safety_checklist",
      "type": "therapy",
      "evidence_level": "low",
      "name_zh": "化疗合并中医药：安全性核对清单",
      "name_en": "Safety checklist for combining TCM with chemotherapy",
      "summary_zh": "给临床沟通用的安全核对要点：明确所用中药/成分/剂型；评估出血风险、肝肾功能、感染风险；记录所有补充剂与草药；出现黄疸加重、持续腹泻/呕吐、发热或出血倾向时需立即就医并暂停补充疗法。",
      "summary_en": "A practical safety checklist for clinical communication when combining TCM/supplements with chemotherapy.",
      "key_points": [
        "每次化疗前复核：草药/补充剂清单（名称、剂型、剂量、品牌）",
        "监测：肝肾功能、凝血/血小板、白细胞/感染风险",
        "出现严重不良反应（发热、出血、黄疸加重、脱水）立即停用并就医"
      ],
      "use_cases": ["门诊沟通", "用药核对", "不良反应早期识别"],
      "stage": ["chemo"],
      "components": {},
      "risks": [
        "潜在药物相互作用（CYP/凝血/免疫）",
        "部分草药/补充剂存在肝毒性或肾毒性风险",
        "未经标准化的制剂可能导致成分与剂量不明"
      ],
      "interactions": [
        "抗凝/抗血小板药：出血风险",
        "免疫治疗：潜在免疫调节影响",
        "糖皮质激素/止吐药等：可能有叠加影响（需医生评估）"
      ],
      "refs": [{ "ref_id": "ref_vella2025_cancers_sr" }]
    }
  ]
}
